MSD Nobivac DHPPI , RL Dog Vaccine

Live attenuated vaccine for immunization of Dogs against canine distemper virus(CDV), canine adenovirus type 1 (ICH), canine parvovirus (CPV) and canine parainfluenza virus (CPi).

Description:
A live attenuated vaccine for the immunization of dogs against canine distemper (CDV), canine contagious hepatitis caused by canine adenovirus type 1 (ICH), canine parvovirus disease (CPV) and respiratory disease caused by canine parainfluenza (CPi) and canine adenovirus type 2 (CAV2)

Composition:
Each dose contains live attenuated strains of:
Canine Parvo virus (strain C 154) ≥10⁷ TCID₅₀
Canine Distemper virus (strain Onderstepoort) ≥ 10⁴ TCID₅₀
Canine Adeno virus type 2 (strain Manhattan LPV3) ≥ 10⁴ TCID₅₀
Canine Para-influenza virus (strain Cornell) ≥10^5.5 TCID₅₀

Nobivac RL

Description:
Vaccine for dogs against Rabies and canine leptospirosis caused by L. interrogans serotype canicola and icterohaemorrhagiae

Composition:
Each dose contains:
  Rabies strain Pasture RIV inducing more than 3 IU
  Leptospira canicola (strain Ca-12-000) ≥ 40 hamster PD₈₀
  Leptospira icterohaemorrhagiae (strain 820k) ≥ 40 hamster PD₈₀.

Indications:
For the active immunization of dogs from 8 weeks of age onwards against rabies and canine leptospirosis caused by L. interrogans serotype canicola and icterohaemorrhagiae

Dosage and Administration:
1 ml by subcutaneous injection. Can be used to reconstitute Nobivac DHPPi. Intended for dogs from 8 weeks of age onwards.

Vaccination Programme:
Nobivac RL is indicated for the basic vaccination schedule with the first vaccination at the age of 8-9 weeks of age, followed by a booster at 12 weeks of age and for annual revaccination (Refer product Leaflet for more information).